Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Debt / NOTE 4.750% 2/1
-
Unit price / market price
-
$0.6956
-
Total 13F principal
-
$99,660,000
-
Principal change
-
+$6,680,000
-
Total reported value
-
$69,257,000
-
Number of holders
-
13
-
Value change
-
+$4,736,156
-
Number of buys
-
6
-
Number of sells
-
7
Institutional Holders of IMMUNOMEDICS INC - NOTE 4.750% 2/1 as of Q2 2016
As of 30 Jun 2016 IMMUNOMEDICS INC - NOTE 4.750% 2/1 had 13 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $99,660,000 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included ORBIMED ADVISORS LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, Castle Creek Arbitrage, LLC, ACUTA CAPITAL PARTNERS, LLC, Tekla Capital Management LLC, Jefferies Group LLC, GEODE CAPITAL MANAGEMENT, LLC, and DEUTSCHE BANK AG\.
This table shows 13 bond principal holders of the security as of 30 Jun 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.